Jamp Pharma Corporation, in consultation with Health Canada, is voluntarily recalling one lot of Jamp-Methotrexate USP 50mg/2mL due to the potential presence of foreign particulate matter.
Methotrexate Injection is administered by health care professionals but Health Canada is also aware that this product may be self-administered by subcutaneous injection (under the skin) by patients at home. The risks associated with subcutaneous injection of foreign particulate matter include local reaction at the injection site and/or swelling or possible allergic reaction and infection.
Jamp-Methotrexate USP 50mg/2mLby Jamp Pharma Corporation (lot: 7801372), DIN 02419173
Consumers who have this product for injection by a healthcare professional or for self-administration at home.
Health Canada is monitoring the recall by Jamp Pharma Corporation and should new information about this recall arise, Health Canada will inform Canadians.
- Call toll-free at 1-866-234-2345
- Visit MedEffect Canada's web page on Adverse Reaction Reporting for information on how to report online, by mail or by fax.
Stay connected with Health Canada and receive the latest advisories and product recalls using
social media tools.
Health Canada
613-957-2983
613-957-2991
1-866 225-0709